Page last updated: 2024-11-04

suramin and Lymphopenia

suramin has been researched along with Lymphopenia in 1 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Lymphopenia: Reduction in the number of lymphocytes.

Research Excerpts

ExcerptRelevanceReference
"Three cohorts of patients with advanced prostate cancer that progressed despite castrate levels of testosterone received oral hydrocortisone plus suramin administered in the following manners: (1) a loading dose of suramin followed by a continuous infusion using an adaptive control program (cohort A); (2) an intermittent schedule using a simplified adaptive control schedule (cohort B); and (3) an empiric dosing regimen (cohort C)."2.68Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer. ( Cohen, L; Curley, T; Dnistrian, A; Kelly, WK; Leibertz, C; Mazumdar, M; Pfister, D; Scher, HI; Schwartz, M; Vlamis, V, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelly, WK1
Scher, HI1
Mazumdar, M1
Pfister, D1
Curley, T1
Leibertz, C1
Cohen, L1
Vlamis, V1
Dnistrian, A1
Schwartz, M1

Trials

1 trial available for suramin and Lymphopenia

ArticleYear
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9

    Topics: Adaptation, Physiological; Aged; Aged, 80 and over; Anemia; Cohort Studies; Drug Administration Sche

1995